Tango Therapeutics, Inc. · NASDAQ:TNGX
Ketchum John B sold 3,333 Tango Therapeutics, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 19, 2026
On Nov 17, 2026, Ketchum John B (Director) sold 3,333 Tango Therapeutics, Inc. shares at US$24.08 for US$80,259 under a trading plan, leaving 21,604 shares. Filed Nov 19, 2026 (Form 4).
- Sold
- 3,333 shares
- Price
- US$24.08
- Value
- US$80,259
- Holding after
- 21,604 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Sale | 3,333 | US$24.08 | 21,604 | Direct |
Source
Download original · View original at SEC
Related
- Tango Therapeutics, Inc.
- Ketchum John B
- Tango Therapeutics, Inc. shareholders
- Form 4 · Ketchum John B · Jun 8, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Nov 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Nov 16, 2026
- Form 4 · Crystal Adam · Nov 13, 2026
- Schedule 13G/A · FMR LLC · Nov 6, 2026
- Form 4 · Crystal Adam · Nov 4, 2026